LIGAND PHARMACEUTICALS INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $121.78 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2026-02-27
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $121.78M.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $43.12M.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $7.30M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $17.95M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value as first filed |
|---|---|---|
| 2025-12-31 | $121.78M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $43.12M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $7.30M 10-K · filed 2026-02-27 | |
| 2022-12-31 | $17.95M 10-K · filed 2025-02-28 | |
| 2022-10-31 | $13.72M 10-K · filed 2025-02-28 | |
| 2021-12-31 | $80.85M 10-K · filed 2024-02-29 | |
| 2020-12-31 | $53.29M 10-K · filed 2023-02-28 | |
| 2019-12-31 | $70.34M 10-K · filed 2022-02-28 | |
| 2018-12-31 | $117.31M 10-K · filed 2021-02-24 | |
| 2017-12-31 | $138.62M 10-K · filed 2018-03-01 | |
| 2016-12-31 | $92.72M 10-K · filed 2017-02-28 | |
| 2015-12-31 | $99.06M 10-K · filed 2016-11-14 | |
| 2015-06-30 | $88.09M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $65.96M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $38.40M 10-K · filed 2015-02-23 | $36.23M 10-K · filed 2014-12-01 |
| 2014-09-30 | $30.34M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $43.47M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $44.23M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $36.23M 10-K/A · filed 2014-12-12 | |
| 2013-09-30 | $26.42M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $20.85M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $10.48M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $5.40M 10-K · filed 2013-03-14 | |
| 2012-09-30 | $2.98M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $2.63M 10-Q/A · filed 2012-11-14 |